Cybin Announces Grant Of Additional US Patent In Support Of Its CYB003 Breakthrough Therapy Program For Major Depressive Disorder
Cybin 宣布授予额外的美国专利,以支持其针对重度抑郁症的 CYB003 突破性疗法计划
Cybin Announces Grant Of Additional US Patent In Support Of Its CYB003 Breakthrough Therapy Program For Major Depressive Disorder
Cybin 宣布授予额外的美国专利,以支持其针对重度抑郁症的 CYB003 突破性疗法计划
使用浏览器的分享功能,分享给你的好友吧